RPG Life Sciences to sell off its biotech unit
To concentrate on expansion of its formulation biz which currently contributes over 60 per cent to the company’s overall sales
RPG…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Intas Pharmaceuticals
Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)
Ranibizumab is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), a common degenerative…
Intas Pharmaceuticals launches INTACEPT, the first etanercept biosimilar
The launch reduces the cost of treatment down to 50 per cent as compared top imported drug
Intas Pharmaceuticals launches biosimilar in Europe
The product has recently been introduced under the brand Accofil and has already won two tenders, in Netherlands and the UK